Disrupted in renal carcinoma 2 (DIRC2), a novel transporter of the lysosomal membrane, is proteolytically processed by cathepsin L.

Savalas LR, Gasnier B, Damme M, Lübke T, Wrocklage C, Debacker C, Jezeqou A, Reinheckel T, Hasilik A, Saftig P, Schröder B (2011)
Biochemical Journal 436(1): 113-121.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ; ; ; ;
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Savalas LR, Gasnier B, Damme M, et al. Disrupted in renal carcinoma 2 (DIRC2), a novel transporter of the lysosomal membrane, is proteolytically processed by cathepsin L. Biochemical Journal. 2011;436(1):113-121.
Savalas, L. R., Gasnier, B., Damme, M., Lübke, T., Wrocklage, C., Debacker, C., Jezeqou, A., et al. (2011). Disrupted in renal carcinoma 2 (DIRC2), a novel transporter of the lysosomal membrane, is proteolytically processed by cathepsin L. Biochemical Journal, 436(1), 113-121.
Savalas, L. R., Gasnier, B., Damme, M., Lübke, T., Wrocklage, C., Debacker, C., Jezeqou, A., Reinheckel, T., Hasilik, A., Saftig, P., et al. (2011). Disrupted in renal carcinoma 2 (DIRC2), a novel transporter of the lysosomal membrane, is proteolytically processed by cathepsin L. Biochemical Journal 436, 113-121.
Savalas, L.R., et al., 2011. Disrupted in renal carcinoma 2 (DIRC2), a novel transporter of the lysosomal membrane, is proteolytically processed by cathepsin L. Biochemical Journal, 436(1), p 113-121.
L.R. Savalas, et al., “Disrupted in renal carcinoma 2 (DIRC2), a novel transporter of the lysosomal membrane, is proteolytically processed by cathepsin L.”, Biochemical Journal, vol. 436, 2011, pp. 113-121.
Savalas, L.R., Gasnier, B., Damme, M., Lübke, T., Wrocklage, C., Debacker, C., Jezeqou, A., Reinheckel, T., Hasilik, A., Saftig, P., Schröder, B.: Disrupted in renal carcinoma 2 (DIRC2), a novel transporter of the lysosomal membrane, is proteolytically processed by cathepsin L. Biochemical Journal. 436, 113-121 (2011).
Savalas, LR, Gasnier, B, Damme, Markus, Lübke, Torben, Wrocklage, C, Debacker, C, Jezeqou, A, Reinheckel, T, Hasilik, A, Saftig, P, and Schröder, Bernd. “Disrupted in renal carcinoma 2 (DIRC2), a novel transporter of the lysosomal membrane, is proteolytically processed by cathepsin L.”. Biochemical Journal 436.1 (2011): 113-121.
This data publication is cited in the following publications:
This publication cites the following data publications:

12 Citations in Europe PMC

Data provided by Europe PubMed Central.

Lysosomal integral membrane protein type-2 (LIMP-2/SCARB2) is a substrate of cathepsin-F, a cysteine protease mutated in type-B-Kufs-disease.
Peters J, Rittger A, Weisner R, Knabbe J, Zunke F, Rothaug M, Damme M, Berkovic SF, Blanz J, Saftig P, Schwake M., Biochem. Biophys. Res. Commun. 457(3), 2015
PMID: 25576872
Signal-peptide-peptidase-like 2a is required for CD74 intramembrane proteolysis in human B cells.
Schneppenheim J, Huttl S, Kruchen A, Fluhrer R, Muller I, Saftig P, Schneppenheim R, Martin CL, Schroder B., Biochem. Biophys. Res. Commun. 451(1), 2014
PMID: 25035924
Automated peptide mapping and protein-topographical annotation of proteomics data.
Videm P, Gunasekaran D, Schroder B, Mayer B, Biniossek ML, Schilling O., BMC Bioinformatics 15(), 2014
PMID: 24946880
Expression analysis of mouse Rhobtb3 using a LacZ reporter and preliminary characterization of a knockout strain.
Lutz J, Grimm-Gunter EM, Joshi P, Rivero F., Histochem. Cell Biol. 142(5), 2014
PMID: 24923387
The intramembrane proteases signal Peptide peptidase-like 2a and 2b have distinct functions in vivo.
Schneppenheim J, Huttl S, Mentrup T, Lullmann-Rauch R, Rothaug M, Engelke M, Dittmann K, Dressel R, Araki M, Araki K, Wienands J, Fluhrer R, Saftig P, Schroder B., Mol. Cell. Biol. 34(8), 2014
PMID: 24492962
Gene disruption of Mfsd8 in mice provides the first animal model for CLN7 disease.
Damme M, Brandenstein L, Fehr S, Jankowiak W, Bartsch U, Schweizer M, Hermans-Borgmeyer I, Storch S., Neurobiol. Dis. 65(), 2014
PMID: 24423645
The tetraspanin CD63 is required for efficient IgE-mediated mast cell degranulation and anaphylaxis.
Kraft S, Jouvin MH, Kulkarni N, Kissing S, Morgan ES, Dvorak AM, Schroder B, Saftig P, Kinet JP., J. Immunol. 191(6), 2013
PMID: 23945142
Heme and FLVCR-related transporter families SLC48 and SLC49.
Khan AA, Quigley JG., Mol. Aspects Med. 34(2-3), 2013
PMID: 23506900
An extended proteome map of the lysosomal membrane reveals novel potential transporters.
Chapel A, Kieffer-Jaquinod S, Sagne C, Verdon Q, Ivaldi C, Mellal M, Thirion J, Jadot M, Bruley C, Garin J, Gasnier B, Journet A., Mol. Cell Proteomics 12(6), 2013
PMID: 23436907
Cell biology and function of neuronal ceroid lipofuscinosis-related proteins.
Kollmann K, Uusi-Rauva K, Scifo E, Tyynela J, Jalanko A, Braulke T., Biochim. Biophys. Acta 1832(11), 2013
PMID: 23402926
Lysosomal membrane proteins and their central role in physiology.
Schwake M, Schroder B, Saftig P., Traffic 14(7), 2013
PMID: 23387372
The intramembrane protease SPPL2a promotes B cell development and controls endosomal traffic by cleavage of the invariant chain.
Schneppenheim J, Dressel R, Huttl S, Lullmann-Rauch R, Engelke M, Dittmann K, Wienands J, Eskelinen EL, Hermans-Borgmeyer I, Fluhrer R, Saftig P, Schroder B., J. Exp. Med. 210(1), 2013
PMID: 23267015

51 References

Data provided by Europe PubMed Central.

Chimeric transcript discovery by paired-end transcriptome sequencing.
Maher CA, Palanisamy N, Brenner JC, Cao X, Kalyana-Sundaram S, Luo S, Khrebtukova I, Barrette TR, Grasso C, Yu J, Lonigro RJ, Schroth G, Kumar-Sinha C, Chinnaiyan AM., Proc. Natl. Acad. Sci. U.S.A. 106(30), 2009
PMID: 19592507

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 21692750
PubMed | Europe PMC

Search this title in

Google Scholar